[Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia]

Med Clin (Barc). 2006 Oct 14;127(14):542-8. doi: 10.1157/13093733.

[Article in Spanish]

Authors

Fernando Rodríguez-Artalejo¹, Enrique Baca, Enrique Esmatjes, Juan Francisco Merino-Torres, Susana Monereo, Basilio Moreno, Teresa Mories, Miquel Roca, Javier Salvador, Anna Sanmartí

Affiliation

¹ Departamento de Medicina Preventiva y Salud Pública, Universidad Autónoma de Madrid, Arzobispo Morcillo s/n, 2829 Madrid, Spain. fernando.artalejo@uam.es

PMID: 17145003
DOI: 10.1157/13093733

No abstract available

Publication types

Review

MeSH terms

Antipsychotic Agents / therapeutic use
Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Cardiovascular Diseases / therapy
Humans
Metabolic Diseases / etiology
Metabolic Diseases / prevention & control*
Metabolic Diseases / therapy
Risk Factors
Schizophrenia / complications*

Substances

Antipsychotic Agents